/
DCF Valuation
Base-case fair value
$-3.32
Intrinsic $-4.43 · 25% MOS
Base-case summary
Our base-case DCF for Bausch Health Companies Inc. (BHC) projects 10 years of free cash flow growth at 2.0% for years 1–5 and 1.0% for years 6–10, anchored to a default 8% growth assumption, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $1.0B in trailing free cash flow, this produces an intrinsic value of $-4.43 per share. A 25% safety margin gives a fair value of $-3.32.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$1.0B
Cash & equivalents
$1.3B
Total debt
$20.8B
Shares outstanding
373M